Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity
NCT ID: NCT02229708
Last Updated: 2019-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
262 participants
INTERVENTIONAL
2014-09-30
2019-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Healthy Weight Across the Pregnancy and Postpartum Period
NCT04253977
Pregnancy Exercise Mode Effect on Childhood Obesity
NCT04805502
Interventions to Reduce Excess Weight Gain in Pregnancy
NCT01643356
Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
NCT00792480
Dietary and Lifestyle Interventions in Obese Pregnant Women
NCT02095028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed research aims to meets the needs of low-income, Black mothers by developing a novel pregnancy intervention that 1) focuses solely on Black women, 2) incorporates Black mothers' information needs, values, and social context, and 3) uses technology to facilitate participant engagement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
The Usual Obstetric Care group will receive usual advice about nutrition and activity during pregnancy from their obstetrician along with some additional information about pregnancy and childbirth through readings from The American College of Obstetricians and Gynecologists. In addition, participants will receive weekly text messages to maintain contact and ensure follow-up.
No interventions assigned to this group
Healthy Lifestlye Group
The Healthy Lifestyle Group will take part in an individual, technology-based behavioral intervention program which will include specific information about nutrition and physical activity, and strategies for helping them make changes to their diet, physical activity, and weight-related behaviors during pregnancy. Participants will receive information through print materials, text messages, a private Facebook group, and in-person visits and phone calls from a health coach who is part of our research team.
Healthy Lifestyle Group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy Lifestyle Group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI at recruitment between 25.0-44.9 kg/m2
* Singleton pregnancy
* Gestational age of ≤ 20 weeks as determined by last menstrual period
* Plan to carry the pregnancy to term and keep the baby
* Own a cell phone with a text messaging plan
* Member of Facebook social networking site
* Able to participate in physical activity
* Participants must be willing to comply with all study-related procedures
Exclusion Criteria
* Uncontrolled hypertension (systolic blood pressure \> 160 or diastolic blood pressure \> 95 mmHg). Participants with controlled hypertension on medication for at least three months are allowable.
* Known atherosclerotic cardiovascular disease
* Known congestive heart failure
* Known diabetes mellitus (type 1 or type 2)
* Uncontrolled thyroid disease. Participants with controlled thyroid disease on medication for at least three months are allowable.
* Known cancer
* Any major active rheumatologic, pulmonary, hepatic, dermatologic disease or inflammatory condition requiring steroids or immune modulating medications
* History of testing HIV positive
* Current smoker or tobacco user
* Current or recent history (past 6 months) of drug or alcohol abuse or dependence
* Participation in any weight control or investigational drug study within 6 weeks of screening
* Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety for successful participation in the study
* Gastrointestinal Disorders (gallbladder disease, Crohn's disease, etc)
* Previous weight loss surgery
* History of bulimia or anorexia
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HRSA/Maternal and Child Health Bureau
FED
Temple University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon J Herring, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Temple University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Temple University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R40MC26818
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
22201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.